Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX1 | Q96LB2 | 7/20 | 0.37 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.37 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.37 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.37 |
| ▸ | GPR3 | P46089 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17109971 | 0.78 | LIMK1 (0.40) | MRGPRX1LIMK1CDK5CDK5R1GPR3 | |
| SCHEMBL24627146 | 0.76 | ELANE (0.41) | GPR3ELANEMEN1ALDH1A1KMT2A | |
| SCHEMBL19162623 | 0.76 | ELANE (0.41) | GPR3ELANEMEN1ALDH1A1KMT2A | |
| SCHEMBL25016632 | 0.75 | ELANE (0.40) | GPR3ELANEMEN1ALDH1A1KMT2A | |
| SCHEMBL12903904 | 0.75 | LIMK1 (0.40) | LIMK1CDK5CDK5R1GPR3ELANE | |
| SCHEMBL924654 | 0.75 | LIMK1 (0.56) | LIMK1CDK5CDK5R1GPR3ALDH1A1 | |
| SCHEMBL7216257 | 0.75 | PDE4A (0.44) | LIMK1CDK5CDK5R1GPR3ELANE | |
| SCHEMBL14090701 | 0.74 | LIMK1 (0.59) | LIMK1CDK5CDK5R1RXFP1HRH4 | |
| SCHEMBL18177882 | 0.74 | GPR3 (0.41) | LIMK1CDK5CDK5R1GPR3ELANE | |
| SCHEMBL19161279 | 0.73 | ATM (0.39) | ELANEMEN1ALDH1A1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200071735-A1 | Compounds for Increasing Lipid Synthesis and Storage | WASE, NISHIKANT | 2020-03-05 | — | — | US | disclosed |
| US-10351883-B2 | Compounds for increasing lipid synthesis and storage | NUTECH VENTURES (US) | 2019-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10351883-B2 | Compounds for increasing lipid synthesis and storage | FASN, LIPC, SREBF2 | MRGPRX1 4216/4885LIMK1 3309/4885CDK5 1090/4885 |
| US-20200071735-A1 | Compounds for Increasing Lipid Synthesis and Storage | FASN, LIPC, SREBF2 | MRGPRX1 4216/4885LIMK1 3309/4885CDK5 1090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.